Cargando…
UCP2 silencing aggravates mitochondrial dysfunction in astrocytes under septic conditions
Uncoupling protein 2 (UCP2) plays a positive role in sepsis. However, the role of UCP2 in experimental sepsis in astrocytes remains unknown. The present study was designed to determine whether UCP2 has a protective effect in an experimental sepsis model in astrocytes asnd to clarify the mechanisms r...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6797937/ https://www.ncbi.nlm.nih.gov/pubmed/31702042 http://dx.doi.org/10.3892/mmr.2019.10721 |
_version_ | 1783459939031711744 |
---|---|
author | Peng, Wanwan Huang, Jinda Zheng, Yijun Ding, Yue Li, Sitao Zhang, Junliang Lyu, Juanjuan Zeng, Qiyi |
author_facet | Peng, Wanwan Huang, Jinda Zheng, Yijun Ding, Yue Li, Sitao Zhang, Junliang Lyu, Juanjuan Zeng, Qiyi |
author_sort | Peng, Wanwan |
collection | PubMed |
description | Uncoupling protein 2 (UCP2) plays a positive role in sepsis. However, the role of UCP2 in experimental sepsis in astrocytes remains unknown. The present study was designed to determine whether UCP2 has a protective effect in an experimental sepsis model in astrocytes asnd to clarify the mechanisms responsible for its neuroprotective effects after sepsis. An experimental astrocyte model mimicking sepsis-induced brain injury was established using lipopolysaccharide (LPS) and interferon (IFN)-γ. Additionally, UCP2 knockdown in astrocytes was achieved by adenovirus transfection. Tumor necrosis factor (TNF)-α and interleukin (IL)-1β activity, mitochondrial membrane potential (MMP) and reactive oxygen species (ROS), and adenosine triphosphate (ATP) levels were assessed. The mitochondrial ultrastructure was evaluated, and the expression of UCP2 was determined by western blotting. LPS with IFN-γ co-stimulation increased the mRNA and protein expression levels of UCP2 in astrocytes, damaged the mitochondrial structure, and accelerated the release of TNF-α and IL-1β, resulting in a decrease in the MMP, and the excessive generation of ROS. Moreover, sepsis also caused a reduction in ATP production. The knockdown of UCP2 exacerbated astrocyte injury and mitochondrial impairment. In conclusion, both the function and morphology of mitochondria were damaged in an experimental model of sepsis in astrocytes, and knockdown of UCP2 using shRNA exacerbated this impairment, suggesting that UCP2 has a positive effect on astrocytes as determined in an experimental sepsis model. |
format | Online Article Text |
id | pubmed-6797937 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | D.A. Spandidos |
record_format | MEDLINE/PubMed |
spelling | pubmed-67979372019-10-22 UCP2 silencing aggravates mitochondrial dysfunction in astrocytes under septic conditions Peng, Wanwan Huang, Jinda Zheng, Yijun Ding, Yue Li, Sitao Zhang, Junliang Lyu, Juanjuan Zeng, Qiyi Mol Med Rep Articles Uncoupling protein 2 (UCP2) plays a positive role in sepsis. However, the role of UCP2 in experimental sepsis in astrocytes remains unknown. The present study was designed to determine whether UCP2 has a protective effect in an experimental sepsis model in astrocytes asnd to clarify the mechanisms responsible for its neuroprotective effects after sepsis. An experimental astrocyte model mimicking sepsis-induced brain injury was established using lipopolysaccharide (LPS) and interferon (IFN)-γ. Additionally, UCP2 knockdown in astrocytes was achieved by adenovirus transfection. Tumor necrosis factor (TNF)-α and interleukin (IL)-1β activity, mitochondrial membrane potential (MMP) and reactive oxygen species (ROS), and adenosine triphosphate (ATP) levels were assessed. The mitochondrial ultrastructure was evaluated, and the expression of UCP2 was determined by western blotting. LPS with IFN-γ co-stimulation increased the mRNA and protein expression levels of UCP2 in astrocytes, damaged the mitochondrial structure, and accelerated the release of TNF-α and IL-1β, resulting in a decrease in the MMP, and the excessive generation of ROS. Moreover, sepsis also caused a reduction in ATP production. The knockdown of UCP2 exacerbated astrocyte injury and mitochondrial impairment. In conclusion, both the function and morphology of mitochondria were damaged in an experimental model of sepsis in astrocytes, and knockdown of UCP2 using shRNA exacerbated this impairment, suggesting that UCP2 has a positive effect on astrocytes as determined in an experimental sepsis model. D.A. Spandidos 2019-11 2019-10-02 /pmc/articles/PMC6797937/ /pubmed/31702042 http://dx.doi.org/10.3892/mmr.2019.10721 Text en Copyright: © Peng et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. |
spellingShingle | Articles Peng, Wanwan Huang, Jinda Zheng, Yijun Ding, Yue Li, Sitao Zhang, Junliang Lyu, Juanjuan Zeng, Qiyi UCP2 silencing aggravates mitochondrial dysfunction in astrocytes under septic conditions |
title | UCP2 silencing aggravates mitochondrial dysfunction in astrocytes under septic conditions |
title_full | UCP2 silencing aggravates mitochondrial dysfunction in astrocytes under septic conditions |
title_fullStr | UCP2 silencing aggravates mitochondrial dysfunction in astrocytes under septic conditions |
title_full_unstemmed | UCP2 silencing aggravates mitochondrial dysfunction in astrocytes under septic conditions |
title_short | UCP2 silencing aggravates mitochondrial dysfunction in astrocytes under septic conditions |
title_sort | ucp2 silencing aggravates mitochondrial dysfunction in astrocytes under septic conditions |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6797937/ https://www.ncbi.nlm.nih.gov/pubmed/31702042 http://dx.doi.org/10.3892/mmr.2019.10721 |
work_keys_str_mv | AT pengwanwan ucp2silencingaggravatesmitochondrialdysfunctioninastrocytesundersepticconditions AT huangjinda ucp2silencingaggravatesmitochondrialdysfunctioninastrocytesundersepticconditions AT zhengyijun ucp2silencingaggravatesmitochondrialdysfunctioninastrocytesundersepticconditions AT dingyue ucp2silencingaggravatesmitochondrialdysfunctioninastrocytesundersepticconditions AT lisitao ucp2silencingaggravatesmitochondrialdysfunctioninastrocytesundersepticconditions AT zhangjunliang ucp2silencingaggravatesmitochondrialdysfunctioninastrocytesundersepticconditions AT lyujuanjuan ucp2silencingaggravatesmitochondrialdysfunctioninastrocytesundersepticconditions AT zengqiyi ucp2silencingaggravatesmitochondrialdysfunctioninastrocytesundersepticconditions |